Granocyte 3433.6MIU
Injection
Additional Offers
Show all
| Alcohol | CONSULT YOUR DOCTOR It is not known whether it is safe to consume alcohol with Granocyte 34. Please consult your doctor. |
| Pregnancy | CONSULT YOUR DOCTOR Granocyte 34 is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it... View More |
| Breastfeeding | SAFE IF PRESCRIBED Granocyte 34 is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby... View More |
| Driving | CONSULT YOUR DOCTOR It is not known whether Granocyte 34 alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate an... View More |
| Kidney | CONSULT YOUR DOCTOR There is limited information available on the use of Granocyte 34 in patients with kidney disease. Please consult your doctor. |
| Liver | CONSULT YOUR DOCTOR There is limited information available on the use of Granocyte 34 in patients with liver disease. Please consult your doctor. |
Introduction
Granocyte 34 is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These... View More
Uses of Granocyte 34
- Infections after chemotherapy
Side effects of Granocyte 34
- Bone pain
- Weakness
- Increased white blood cell count
- Low blood platelets
- Back pain
- Increased liver enzymes
- Headache
How to use Granocyte 34
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Granocyte 34 works
Granocyte 34 is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections. .
What if you forget to take Granocyte 34?
If you miss a dose of Granocyte 34, please consult your doctor.
- Granocyte 34 Powder for Injection reduces the risk of infection in people treated with chemotherapy.
- It is usually given as a daily injection into the tissue just under the skin or into the vein.
- You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
- Store it in the refrigerator, protect it from light, and don't shake it.
- For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
- Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
- Use caution while driving or doing anything that requires concentration as Granocyte 34 Powder for Injection may cause dizziness.
- Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment... View More
- Stop taking Granocyte 34 Powder for Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathi... View More
Indication
Neutropenia, Reduce the risk of life-threatening infection in patients with neutropenia after cytotoxic chemotherapy.
Adult Dose
Intravenous Neutropenia following bone marrow transplantation Adult: 19.2 million IU/m2 or 150 mcg/m2 daily by IV infusion started the day after trans... View More
Child Dose
Intravenous Neutropenia following bone marrow transplantation Child: >2 yr: 19.2 million IU/m2 or 150 mcg/m2 daily by IV infusion started the day afte... View More
Contraindication
Contraindicated in patients with bone marrow cancer, children less than 2 years, and hypersensitivity.
Mode of Action
Lenograstrim (rHuG-CSF) belongs to the cytokine group of biologically active proteins which regulate cell differentiation and cell growth. rHuG-CSF is a... View More
Precaution
Premalignant or malignant myeloid condition; sickle-cell disease; osteoporotic bone disease; signs of pulmonary infiltrates (withdraw treatment). Monito... View More
Side Effect
Musculoskeletal - Musculoskeletal pain, bone pain, splenic enlargement and osteoporosis. Gastrointestinal - Nausea, diarrhea and loss of appetite. Blo... View More
Interaction
Increased risk of myelosuppression with myelosuppressive antineoplastic agents; increased pulmonary toxicity with bleomycin and cyclophosphamide.
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More